Discontinued — last reported Q4 '22
Investing
CapEx
Incyte CapEx decreased by 23.5% to $21.27M in Q4 2022 compared to the prior quarter. Year-over-year, this metric declined by 38.3%, from $34.46M to $21.27M.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ4 2022Feb 7, 2023
How to read this metric
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
Detailed definition
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Peer comparison
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
Metric ID:
capital_expendituresHistorical Data
7 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | |
|---|---|---|---|---|---|---|---|
| Value | $66.31M | $32.15M | $34.46M | $17.01M | $11.74M | $27.81M | $21.27M |
| QoQ Change | — | -51.5% | +7.2% | -50.7% | -30.9% | +136.8% | -23.5% |
| YoY Change | — | — | — | — | -82.3% | -13.5% | -38.3% |
Range$11.74M – $66.31M
CAGR-53.1%
Avg YoY Growth-44.7%
Median YoY Growth-38.3%
CapEx at Other Companies
Frequently Asked Questions
- What is Incyte's capex?
- Incyte (INCY) reported capex of $21.27M in Q4 2022.
- How has Incyte's capex changed year-over-year?
- Incyte's capex decreased by 38.3% year-over-year, from $34.46M to $21.27M.
- What does capex mean?
- Cash spent on purchasing or maintaining physical assets like machinery and facilities.